Vistin Pharma ASA (LON:0RAM)

Market Cap	76.72M
Revenue (ttm)	30.20M
Net Income (ttm)	4.41M
Shares Out	n/a
EPS (ttm)	0.10
PE Ratio	17.39
Forward PE	n/a
Dividend	0.07 (0.31%)
Ex-Dividend Date	Jun 4, 2025

Volume	31
Average Volume	724
Open	n/a
Previous Close	n/a
Day's Range	n/a
52-Week Range	1.62 - 1.94
Beta	1.03
RSI	48.93
Earnings Date	Apr 25, 2025

About Vistin Pharma ASA

Vistin Pharma ASA, through its subsidiary, Vistin Pharma AS, produces and sells active pharmaceutical ingredients (APIs) worldwide. It offers metformin HCl APIs and direct compressive granulates for the pharmaceutical industry. Vistin Pharma ASA was founded in 1969 and is headquartered in Oslo, Norway.

• Industry: Medicinal Chemicals and Botanical Products
• Founded: 1969
• Employees: 77
• Stock Exchange: London Stock Exchange
• Ticker Symbol: 0RAM

Financial Performance

In 2024, Vistin Pharma ASA's revenue was 429.50 million, a decrease of -2.01% compared to the previous year's 438.33 million. Earnings were 62.75 million, an increase of 37.63%.

Financial numbers in NOK